Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials
In Brief: NIH Reviewers, Advisors To Get Increase In Honoraria; Price Leaving NCI for Maryland
Recision, 1981 Budget Threats Hangover NCI
Frelick Heads ACCC, Kerman Names President-Elect
CCIRC Told Group Radiation Studies Cost $20,000 Per 25 Patients
Skipper To Receive Bristol-Myers Award
Pathology Review Confirms Reserpine As Carcinogen
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast